A matched cohort study evaluating whether spironolactone or tetracycline-class antibiotic use among female acne patients is associated with breast cancer development risk

David Garate, Christopher J. Thang, George Golovko, Michael G. Wilkerson, John S. Barbieri

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Article number196
JournalArchives of Dermatological Research
Issue number5
StatePublished - Jul 2024


  • Acne
  • Acne treatment
  • Breast cancer
  • Medical dermatology
  • Spironolactone
  • Tetracyclines

ASJC Scopus subject areas

  • Dermatology

Cite this